Biotechs face upward battle with recruiting patients on obesity trials
As the obesity space becomes more congested, clinical trial recruitment has become a larger issue for small biotechs.
As the obesity space becomes more congested, clinical trial recruitment has become a larger issue for small biotechs.
What's Your Reaction?
